Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma

BACKGROUND: Over the past four decades, outcomes for osteosarcoma patients have plateaued as there have been few emerging therapies showing clinical results. Thus, the identification of novel biomarkers and therapeutic strategies are urgently needed to address these primary obstacles in patient care...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Wenlong, Dean, Dylan C., Hornicek, Francis J., Spentzos, Dimitrios, Hoffman, Robert M., Shi, Huirong, Duan, Zhenfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222246/
https://www.ncbi.nlm.nih.gov/pubmed/32426053
http://dx.doi.org/10.1177/1758835920922055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222246/
https://www.ncbi.nlm.nih.gov/pubmed/32426053
http://dx.doi.org/10.1177/1758835920922055

Ejemplares similares